Open access
Sep 2026
437. Development of novel add-on treatment of cognitive dysfunction in schizophrenia
Preliminary data show that the butyryl cholinesterase inhibitor GUK1811 could modulate glutmatergic transmission in the hippocampus, and may, thus, have a potential to ameliorate cognitive dysfunction related to this brain region in schizophrenia.
K. Jardemark, J. Bruton, M. Shahid et al.
· International Journal of Neu... · 0 citations